Etiometry Expands its Clinical Decision-Support Software with a NICU Focus

BOSTON, September 1st, 2020 – Etiometry, Inc., the leader in clinical decision-support software for the intensive care environment, is expanding their efforts into neonatal intensive care units. The announcement comes as Etiometry recognizes the work and dedication of clinicians improving the health of the most vulnerable patients during NICU Awareness Month, which kicks-off today. Advancements…

Digital Health Company Earns FDA Clearance for Second Patient Risk Index

BOSTON, December 10th, 2019 – Etiometry Inc., a leading digital health company, today announced the FDA clearance of their second algorithm, the Inadequate Ventilation of Carbon Dioxide (IVCO2) Index™. The IVCO2 Index, along with the already cleared Inadequate Delivery of Oxygen (IDO2) Index™, will be displayed on Etiometry’s critical care software platform which is utilized…

Etiometry Expands Leadership with New CEO

BOSTON, November 7th, 2019 – Etiometry Inc., a leading digital health company which developed a critical care analytics platform, announced today the recent expansion of their leadership team. Shane Cooke, was recently appointed as President and Chief Executive Officer, joining the growing company as it continues to expand its presence in current and new markets.…

Etiometry’s Top Technology Advancements in 2018

BOSTON, December 19, 2018 – After reading this, you’ll be racing back to your monitors to explore the latest Etiometry updates you might’ve missed in 2018. Traversing through time on the Etiometry Platform is smoother than ever before. Etiometry experts implemented time navigation improvements with an emphasis on touchscreen capabilities and usability. The Time Navigation…

Study Finds Hospitals Reduce Pediatric Patient Length of Stay by 25% by Deploying Etiometry Risk Analytics

Results of a Multi-Center, Retrospective Cohort Analysis of All Neonates Admitted to the CICU at Boston Children’s Hospital and the Hospital for Sick Children, Toronto Boston, December 19, 2017—Etiometry, a pioneering leader in next-generation patient monitoring, announced today that a study presented in the American Heart Association (AHA) Scientific Sessions 2017 demonstrates the capability of…

Etiometry Receives FDA 510(k) Clearance to Expand the Indications on Its IDO2 Index Powered by Risk Analytics

Hospitals Can Expand the Intelligent Monitoring Provided by Etiometry’s Inadequate Oxygen Delivery Index to Patients Up to 12 Years of Age BOSTON, June 12, 2017— Etiometry, a pioneering leader in next-generation patient monitoring, has received FDA Clearance for its Inadequate Oxygen Delivery (IDO2) Index for monitoring ICU patients 12 years or younger. Originally cleared by…